131 related articles for article (PubMed ID: 9700207)
1. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.
Holmes C; Arranz MJ; Powell JF; Collier DA; Lovestone S
Hum Mol Genet; 1998 Sep; 7(9):1507-9. PubMed ID: 9700207
[TBL] [Abstract][Full Text] [Related]
2. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.
Assal F; Alarcón M; Solomon EC; Masterman D; Geschwind DH; Cummings JL
Arch Neurol; 2004 Aug; 61(8):1249-53. PubMed ID: 15313842
[TBL] [Abstract][Full Text] [Related]
3. Depression in Alzheimer's disease: the effect of serotonin receptor gene variation.
Holmes C; Arranz M; Collier D; Powell J; Lovestone S
Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):40-3. PubMed ID: 12707936
[TBL] [Abstract][Full Text] [Related]
4. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Nacmias B; Tedde A; Forleo P; Piacentini S; Guarnieri BM; Bartoli A; Ortenzi L; Petruzzi C; Serio A; Marcon G; Sorbi S
Biol Psychiatry; 2001 Sep; 50(6):472-5. PubMed ID: 11566166
[TBL] [Abstract][Full Text] [Related]
5. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.
Pritchard AL; Harris J; Pritchard CW; Coates J; Haque S; Holder R; Bentham P; Lendon CL
Neurobiol Aging; 2008 Mar; 29(3):341-7. PubMed ID: 17098333
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease.
Thome J; Retz W; Baader M; Pesold B; Hu M; Cowen M; Durany N; Adler G; Henn FA; Rösler M
J Neural Transm (Vienna); 2001; 108(10):1175-80. PubMed ID: 11725820
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.
Holmes C; McCulley M; Nicoll JA; Alder JT; Chen CP; Francis PT
Neurosci Lett; 2007 Jun; 420(1):58-60. PubMed ID: 17481814
[TBL] [Abstract][Full Text] [Related]
8. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease.
Rocchi A; Micheli D; Ceravolo R; Manca ML; Tognoni G; Siciliano G; Murri L
Genet Test; 2003; 7(4):309-14. PubMed ID: 15000807
[TBL] [Abstract][Full Text] [Related]
9. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia.
Bondy B; Spaeth M; Offenbaecher M; Glatzeder K; Stratz T; Schwarz M; de Jonge S; Krüger M; Engel RR; Färber L; Pongratz DE; Ackenheil M
Neurobiol Dis; 1999 Oct; 6(5):433-9. PubMed ID: 10527809
[TBL] [Abstract][Full Text] [Related]
10. The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.
Tang L; Wang Y; Chen Y; Chen L; Zheng S; Bao M; Xiang J; Luo H; Li J; Li Y
Biomed Res Int; 2017; 2017():5320135. PubMed ID: 29349076
[TBL] [Abstract][Full Text] [Related]
11. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
12. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
13. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Masellis M; Basile V; Meltzer HY; Lieberman JA; Sevy S; Macciardi FM; Cola P; Howard A; Badri F; Nöthen MM; Kalow W; Kennedy JL
Neuropsychopharmacology; 1998 Aug; 19(2):123-32. PubMed ID: 9629566
[TBL] [Abstract][Full Text] [Related]
14. The study of genetic polymorphisms related to serotonin in Alzheimer's disease: a new perspective in a heterogenic disorder.
Oliveira JR; Zatz M
Braz J Med Biol Res; 1999 Apr; 32(4):463-7. PubMed ID: 10347811
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study.
Fehr C; Szegedi A; Anghelescu I; Klawe C; Hiemke C; Dahmen N
Psychiatr Genet; 2000 Jun; 10(2):59-65. PubMed ID: 10994642
[TBL] [Abstract][Full Text] [Related]
16. Clozapine response and the 5HT2C Cys23Ser polymorphism.
Malhotra AK; Goldman D; Ozaki N; Rooney W; Clifton A; Buchanan RW; Breier A; Pickar D
Neuroreport; 1996 Sep; 7(13):2100-2. PubMed ID: 8930967
[TBL] [Abstract][Full Text] [Related]
17. The serotonin transporter (5-HTTLPR) but not serotonin receptor (5-HT2C Cys23Ser) variant is associated with bipolar I disorder in Kurdish population from Western Iran.
Mohammadi S; Khazaie H; Rahimi Z; Vaisi-Raygani A; Zargooshi N; Rahimi Z
Neurosci Lett; 2015 Mar; 590():91-5. PubMed ID: 25596490
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Craig D; Donnelly C; Hart D; Carson R; Passmore P
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):126-8. PubMed ID: 16967466
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction.
Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A
Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580
[TBL] [Abstract][Full Text] [Related]
20. Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder.
Gutiérrez B; Arias B; Papiol S; Rosa A; Fañanás L
Neurosci Lett; 2001 Aug; 309(2):135-7. PubMed ID: 11502363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
